JNJ vs. XOM: Johnson & Johnson vs. ExxonMobil Stock Comparison

November 11, 2026

How do Johnson & Johnson (JNJ) and ExxonMobil (XOM) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Johnson & Johnson (JNJ) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas ExxonMobil (XOM) belongs to Energy (Energy) — their GICS classifications point to very different parts of the market.

Company profile comparison for Johnson & Johnson (JNJ) and ExxonMobil (XOM)
Profile Item	JNJ	XOM
Name	Johnson & Johnson	ExxonMobil Holdings Corporation
Country/Region	United States	United States
GICS Sector	Health Care	Energy
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences	Energy
GICS Industry	Pharmaceuticals	Oil, Gas & Consumable Fuels
GICS Sub-Industry	Pharmaceuticals	Integrated Oil & Gas
Market Capitalization	664.95 billion USD	676.62 billion USD
Currency	USD	USD
Exchange	NYSE	NYSE
Listing Date	January 2, 1962	January 2, 1962
Security Type	Common Stock	Common Stock

Price Performance

Cumulative Growth

JNJ

XOM

GSPC

Johnson & Johnson (JNJ) vs. ExxonMobil (XOM), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for Johnson & Johnson (JNJ) and ExxonMobil (XOM). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for Johnson & Johnson (JNJ) and ExxonMobil (XOM). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Johnson & Johnson (JNJ) and ExxonMobil (XOM)
Metric	JNJ	XOM
Total Return (1Y)	53.82%	44.48%
Total Return (3Y, Annualized)	27.51%	20.83%
Total Return (5Y, Annualized)	14.71%	24.20%

Risk Profile

Drawdown History

JNJ

XOM

GSPC

Johnson & Johnson (JNJ) vs. ExxonMobil (XOM), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for Johnson & Johnson (JNJ) and ExxonMobil (XOM). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Johnson & Johnson (JNJ) and ExxonMobil (XOM)
Metric	JNJ	XOM
Volatility (1Y, Annualized)	21.23%	27.17%
Beta (5Y)	0.21	0.19
Max Drawdown (5Y)	-18.41%	-20.51%
Avg. Volume (3M)	6.93M	13.57M

Risk-Adjusted Performance

Risk-Return Positioning

JNJ and XOM are plotted by 1-year volatility (risk) and 1-year return. Each dashed Capital Allocation Line uses that stock's own industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Johnson & Johnson (JNJ) and ExxonMobil (XOM)
Metric	JNJ	XOM
Sharpe Ratio (1Y)	2.33	1.48
Sortino Ratio (1Y)	3.66	2.17

Profitability

ROE (TTM)

Johnson & Johnson (JNJ) at 20.02% sits in the top ROE quartile, while ExxonMobil (XOM) at 15.53% is closer to the peer norm — stronger capital efficiency for JNJ.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

20.02%

Max: 109.18%
JNJ: 20.02%
Q3: 6.23%
Median: -26.66%
Q1: -64.05%
Min: -167.77%

XOM

Energy industry group

15.53%

Max: 53.85%
Q3: 24.79%
XOM: 15.53%
Median: 12.85%
Q1: 2.03%
Min: -29.09%

Johnson & Johnson (JNJ) vs. ExxonMobil (XOM): A comparison of their ROE against their respective Pharmaceuticals, Biotechnology & Life Sciences and Energy industry group benchmarks.

Net Margin (TTM)

Johnson & Johnson (JNJ) at 16.20% retains a top-quartile share of revenue as profit, ahead of ExxonMobil (XOM) at 10.46%, which keeps about the industry-typical share.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

16.20%

Max: 18.05%
JNJ: 16.20%
Q3: 4.78%
Median: 0.00%
Q1: -4.14%
Min: -17.05%

XOM

Energy industry group

10.46%

Max: 56.92%
Q3: 22.92%
XOM: 10.46%
Median: 10.10%
Q1: 0.07%
Min: -27.38%

Johnson & Johnson (JNJ) vs. ExxonMobil (XOM): A comparison of their net margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Energy industry group benchmarks.

Operating Margin (TTM)

Johnson & Johnson (JNJ) at 25.74% operates in the top operating margin quartile, ahead of ExxonMobil (XOM) at 16.98%, which runs around its industry’s norm.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

25.74%

Max: 83.12%
JNJ: 25.74%
Q3: 14.77%
Median: 0.00%
Q1: -78.82%
Min: -207.40%

XOM

Energy industry group

16.98%

Max: 71.31%
Q3: 33.75%
Median: 18.73%
XOM: 16.98%
Q1: 6.94%
Min: -24.52%

Johnson & Johnson (JNJ) vs. ExxonMobil (XOM): A comparison of their operating margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Energy industry group benchmarks.

Profitability Metrics

Profitability metrics for Johnson & Johnson (JNJ) and ExxonMobil (XOM)
Metric	JNJ	XOM
ROE (TTM)	20.02%	15.53%
ROA (TTM)	8.46%	6.75%
Net Margin (TTM)	16.20%	10.46%
Operating Margin (TTM)	25.74%	16.98%
Gross Margin (TTM)	67.78%	29.81%

Growth

Revenue Growth

Both Johnson & Johnson (JNJ) at 6.05% and ExxonMobil (XOM) at -4.52% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Johnson & Johnson (JNJ) vs. ExxonMobil (XOM): A comparison of their Revenue Growth across different time periods.

EPS Growth

Johnson & Johnson (JNJ) at 90.50% sits in the top EPS growth quartile, while ExxonMobil (XOM) at -14.54% is closer to the peer norm — faster per-share earnings growth for JNJ.

Johnson & Johnson (JNJ) vs. ExxonMobil (XOM): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Johnson & Johnson (JNJ) and ExxonMobil (XOM)
Metric	JNJ	XOM
Revenue Growth (YoY)	6.05%	-4.52%
Revenue Growth (3Y CAGR)	5.60%	-6.69%
EPS Growth (YoY)	90.50%	-14.54%
EPS Growth (3Y CAGR)	17.90%	-20.35%

Financial Strength

Current Ratio (MRQ)

ExxonMobil (XOM) at 1.19 keeps current ratio within its industry’s typical mid-range, while Johnson & Johnson (JNJ) at 1.02 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for JNJ.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.02

Max: 25.13
Q3: 12.13
Median: 5.52
Q1: 2.47
JNJ: 1.02
Min: 0.10

XOM

Energy industry group

1.19

Max: 3.64
Q3: 2.21
Median: 1.41
XOM: 1.19
Q1: 0.88
Min: 0.24

Johnson & Johnson (JNJ) vs. ExxonMobil (XOM): A comparison of their current ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Energy industry group benchmarks.

Debt / Equity (MRQ)

ExxonMobil (XOM) at 0.13 keeps leverage in the lower industry quartile, while Johnson & Johnson (JNJ) at 0.55 runs a more typical debt-to-equity mix.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.55

Max: 1.42
Q3: 0.65
JNJ: 0.55
Median: 0.15
Q1: 0.02
Min: 0.00

XOM

Energy industry group

0.13

Max: 1.75
Q3: 0.93
Median: 0.54
Q1: 0.30
XOM: 0.13
Min: 0.00

Johnson & Johnson (JNJ) vs. ExxonMobil (XOM): A comparison of their debt-to-equity ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Energy industry group benchmarks.

Financial Strength Metrics

Financial strength metrics for Johnson & Johnson (JNJ) and ExxonMobil (XOM)
Metric	JNJ	XOM
Current Ratio (MRQ)	1.02	1.19
Debt / Equity (MRQ)	0.55	0.13
Net Debt / EBITDA	0.79	0.28

Dividends

Dividend Yield (TTM)

ExxonMobil (XOM) at 2.49% pays an industry-typical yield; Johnson & Johnson (JNJ) at 1.94% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.94%

JNJ: 1.94%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

XOM

Energy industry group

2.49%

Max: 8.57%
Q3: 3.58%
XOM: 2.49%
Median: 1.71%
Q1: 0.00%
Min: 0.00%

Johnson & Johnson (JNJ) vs. ExxonMobil (XOM): A comparison of their dividend yield against their respective Pharmaceuticals, Biotechnology & Life Sciences and Energy industry group benchmarks.

Dividend Payout Ratio (TTM)

ExxonMobil (XOM) at 42.39% keeps its payout in the industry’s typical band, while Johnson & Johnson (JNJ) at 80.12% pays out more than any of its peers — the most stretched cover in its group.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

80.12%

JNJ: 80.12%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

XOM

Energy industry group

42.39%

Max: 133.24%
Q3: 53.31%
XOM: 42.39%
Median: 25.24%
Q1: 0.00%
Min: 0.00%

Johnson & Johnson (JNJ) vs. ExxonMobil (XOM): A comparison of their payout ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Energy industry group benchmarks.

Dividend Metrics

Dividend metrics for Johnson & Johnson (JNJ) and ExxonMobil (XOM)
Metric	JNJ	XOM
Dividend Yield (TTM)	1.94%	2.49%
Dividend Payout Ratio (TTM)	80.12%	42.39%

Valuation

P/E Ratio (TTM)

Both Johnson & Johnson (JNJ) at 41.92 and ExxonMobil (XOM) at 17.06 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

41.92

Max: 85.34
Q3: 43.46
JNJ: 41.92
Median: 26.69
Q1: 13.30
Min: 0.07

XOM

Energy industry group

17.06

Max: 39.54
Q3: 21.72
XOM: 17.06
Median: 12.19
Q1: 7.71
Min: 2.99

Johnson & Johnson (JNJ) vs. ExxonMobil (XOM): A comparison of their P/E ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Energy industry group benchmarks.

P/S Ratio (TTM)

On P/S ratio, both Johnson & Johnson (JNJ) at 6.69 and ExxonMobil (XOM) at 1.74 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.69

Max: 58.18
Q3: 25.77
Median: 7.30
JNJ: 6.69
Q1: 3.01
Min: 0.01

XOM

Energy industry group

1.74

Max: 5.40
Q3: 2.85
XOM: 1.74
Median: 1.69
Q1: 0.88
Min: 0.00

Johnson & Johnson (JNJ) vs. ExxonMobil (XOM): A comparison of their P/S ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Energy industry group benchmarks.

P/B Ratio (MRQ)

Both Johnson & Johnson (JNJ) at 8.16 and ExxonMobil (XOM) at 2.55 carry a premium to book value versus peers, sitting in the upper P/B ratio quartile of their industries.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.16

Max: 13.53
JNJ: 8.16
Q3: 6.54
Median: 3.25
Q1: 1.69
Min: -5.59

XOM

Energy industry group

2.55

Max: 4.21
XOM: 2.55
Q3: 2.38
Median: 1.51
Q1: 1.08
Min: 0.01

Johnson & Johnson (JNJ) vs. ExxonMobil (XOM): A comparison of their P/B ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Energy industry group benchmarks.

Valuation Metrics

Valuation metrics for Johnson & Johnson (JNJ) and ExxonMobil (XOM)
Metric	JNJ	XOM
P/E Ratio (TTM)	41.92	17.06
P/S Ratio (TTM)	6.69	1.74
P/B Ratio (MRQ)	8.16	2.55
Free Cash Flow Yield (TTM)	2.78%	4.19%